VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 733 filers reported holding VANECK VECTORS ETF TR in Q2 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $164,161,791 | -18.9% | 6,100,401 | -9.3% | 0.37% | -17.0% |
Q2 2023 | $202,501,824 | +9.8% | 6,725,401 | +17.9% | 0.44% | +17.0% |
Q1 2023 | $184,481,342 | +97.5% | 5,702,669 | +74.9% | 0.38% | +158.2% |
Q4 2022 | $93,430,253 | +173.4% | 3,259,953 | +130.1% | 0.15% | +175.5% |
Q3 2022 | $34,174,000 | +128.6% | 1,416,901 | +159.5% | 0.05% | +253.3% |
Q2 2022 | $14,952,000 | -81.7% | 546,101 | -74.3% | 0.02% | -64.3% |
Q1 2022 | $81,615,000 | -1.3% | 2,128,161 | -17.6% | 0.04% | -44.0% |
Q4 2021 | $82,731,000 | -18.4% | 2,583,007 | -24.9% | 0.08% | -2.6% |
Q3 2021 | $101,351,000 | -22.1% | 3,439,201 | -10.2% | 0.08% | -33.0% |
Q2 2021 | $130,185,000 | +10.4% | 3,831,201 | +5.6% | 0.12% | +12.7% |
Q1 2021 | $117,950,000 | -43.4% | 3,629,075 | -37.2% | 0.10% | -33.8% |
Q4 2020 | $208,275,000 | +14.8% | 5,782,339 | +24.9% | 0.15% | +14.9% |
Q3 2020 | $181,356,000 | +48.9% | 4,631,168 | +39.5% | 0.13% | -5.6% |
Q2 2020 | $121,804,000 | +47.3% | 3,320,709 | -7.4% | 0.14% | +34.0% |
Q1 2020 | $82,666,000 | +19.2% | 3,587,877 | +51.4% | 0.11% | +32.5% |
Q4 2019 | $69,367,000 | -26.9% | 2,369,036 | -33.4% | 0.08% | -25.2% |
Q3 2019 | $94,957,000 | -30.5% | 3,555,032 | -33.5% | 0.11% | -27.7% |
Q2 2019 | $136,705,000 | +148.9% | 5,348,530 | +118.3% | 0.15% | +134.9% |
Q1 2019 | $54,934,000 | -57.5% | 2,450,222 | -60.0% | 0.06% | -63.2% |
Q4 2018 | $129,333,000 | +247.7% | 6,132,338 | +205.4% | 0.17% | +271.7% |
Q3 2018 | $37,193,000 | -73.1% | 2,008,201 | -67.5% | 0.05% | -76.4% |
Q2 2018 | $138,011,000 | +74.7% | 6,186,057 | +72.1% | 0.20% | +84.0% |
Q1 2018 | $79,014,000 | -67.6% | 3,594,788 | -65.7% | 0.11% | -68.1% |
Q4 2017 | $243,852,000 | -23.4% | 10,492,701 | -24.3% | 0.33% | -36.9% |
Q3 2017 | $318,448,000 | +25.7% | 13,869,767 | +20.9% | 0.53% | +7.1% |
Q2 2017 | $253,289,000 | -5.0% | 11,471,501 | -1.9% | 0.49% | -10.7% |
Q1 2017 | $266,724,000 | +22.3% | 11,693,101 | +12.2% | 0.55% | +28.8% |
Q4 2016 | $218,025,000 | +55.2% | 10,421,868 | +96.1% | 0.43% | +63.6% |
Q3 2016 | $140,469,000 | -7.2% | 5,314,570 | -2.7% | 0.26% | -12.7% |
Q2 2016 | $151,368,000 | – | 5,462,401 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |